BioNTech

BioNTech

Develops personalized immunotherapies with a focus on cancer medicine. Learn more

Launch date
Employees
Market cap
CAD40.0b
Enterprise valuation
CAD14.4b (Public information from Sep 2024)
Company register number HRB 48720 (Mainz)
Mainz Rhineland-Palatinate (HQ)
Authorizing premium user...